HeartFlow CEO and leadership

I co-founded Cardiovascular Simulation, Inc. in 2007 and HeartFlow, Inc. in 2010. I am currently the Chief Technology Officer at HeartFlow. HeartFlow is creating the future of personalized medicine by providing physicians and patients with quantitative data generated by image-based computer models of blood flow for maintaining and restoring cardiovascular health. Prior to that I was an Associate Professor of Bioengineering and Surgery at Stanford University. I joined the faculty at Stanford in 1997. At Stanford, I focused on the development of computer modeling and imaging techniques for cardiovascular disease research, device design and surgery planning. My early research contributions included the first three-dimensional simulations of blood flow in the human abdominal aorta and the first simulations of blood flow in vascular models created from medical imaging data. I started the field of predictive, simulation-based medicine by describing the application of computational fluid dynamics to predict outcomes of cardiovascular interventions in individual patients. I received the “Young Investigator in Computational Mechanics Award” in 2002 from the International Association for Computational Mechanics and the “R.H. Gallagher Young Investigator in Computational Mechanics” from the United States Association for Computational Mechanics in 2003. In 2007 I was elected as a Fellow of the American Institute for Medical and Biological Engineering (AIMBE). I have published over 450 peer-reviewed journal and conference papers in the field of cardiovascular bioengineering and medicine. I have more than 200 awarded U.S. and international patents.Specialties: Cardiovascular Bioengineering, Patient-specific modeling of blood flow and wall motion, magnetic resonance imaging techniques to measure blood flow during dynamic exercise conditions, tracking the motion of blood vessels over the cardiac cycle, and determining realistic loading conditions for modeling implanted devices.

Dr. Rogers currently serves as the Chief Medical Officer of HeartFlow, Inc., a private cardiovascular diagnostics company based in California. Prior to joining HeartFlow, Dr. Rogers was the Chief Scientific Officer and Global Head of Research and Development at Cordis Corporation, a Johnson & Johnson company. Before Cordis, he was an Associate Professor of Medicine and Director of the Cardiac Catheterization Laboratory at Harvard Medical School, Brigham and Women’s Hospital in Boston.

I co-founded Cardiovascular Simulation, Inc. in 2007 and HeartFlow, Inc. in 2010. I am currently the Chief Technology Officer at HeartFlow. HeartFlow is creating the future of personalized medicine by providing physicians and patients with quantitative data generated by image-based computer models of blood flow for maintaining and restoring cardiovascular health. Prior to that I was an Associate Professor of Bioengineering and Surgery at Stanford University. I joined the faculty at Stanford in 1997. At Stanford, I focused on the development of computer modeling and imaging techniques for cardiovascular disease research, device design and surgery planning. My early research contributions included the first three-dimensional simulations of blood flow in the human abdominal aorta and the first simulations of blood flow in vascular models created from medical imaging data. I started the field of predictive, simulation-based medicine by describing the application of computational fluid dynamics to predict outcomes of cardiovascular interventions in individual patients. I received the “Young Investigator in Computational Mechanics Award” in 2002 from the International Association for Computational Mechanics and the “R.H. Gallagher Young Investigator in Computational Mechanics” from the United States Association for Computational Mechanics in 2003. In 2007 I was elected as a Fellow of the American Institute for Medical and Biological Engineering (AIMBE). I have published over 450 peer-reviewed journal and conference papers in the field of cardiovascular bioengineering and medicine. I have more than 200 awarded U.S. and international patents.Specialties: Cardiovascular Bioengineering, Patient-specific modeling of blood flow and wall motion, magnetic resonance imaging techniques to measure blood flow during dynamic exercise conditions, tracking the motion of blood vessels over the cardiac cycle, and determining realistic loading conditions for modeling implanted devices.

I co-founded Cardiovascular Simulation, Inc. in 2007 and HeartFlow, Inc. in 2010. I am currently the Chief Technology Officer at HeartFlow. HeartFlow is creating the future of personalized medicine by providing physicians and patients with quantitative data generated by image-based computer models of blood flow for maintaining and restoring cardiovascular health. Prior to that I was an Associate Professor of Bioengineering and Surgery at Stanford University. I joined the faculty at Stanford in 1997. At Stanford, I focused on the development of computer modeling and imaging techniques for cardiovascular disease research, device design and surgery planning. My early research contributions included the first three-dimensional simulations of blood flow in the human abdominal aorta and the first simulations of blood flow in vascular models created from medical imaging data. I started the field of predictive, simulation-based medicine by describing the application of computational fluid dynamics to predict outcomes of cardiovascular interventions in individual patients. I received the “Young Investigator in Computational Mechanics Award” in 2002 from the International Association for Computational Mechanics and the “R.H. Gallagher Young Investigator in Computational Mechanics” from the United States Association for Computational Mechanics in 2003. In 2007 I was elected as a Fellow of the American Institute for Medical and Biological Engineering (AIMBE). I have published over 450 peer-reviewed journal and conference papers in the field of cardiovascular bioengineering and medicine. I have more than 200 awarded U.S. and international patents.Specialties: Cardiovascular Bioengineering, Patient-specific modeling of blood flow and wall motion, magnetic resonance imaging techniques to measure blood flow during dynamic exercise conditions, tracking the motion of blood vessels over the cardiac cycle, and determining realistic loading conditions for modeling implanted devices.

Dana G. Mead, Jr. joined Intersect ENT’s board of directors in June 2007. Since May 2019, Dana has served as President and CEO of HeartFlow, a cardiovascular diagnostics company. Previously Dana served as President and CEO of BVI Medical, Inc., a medical device company in ophthalmology. He spent 10 years as a partner at Kleiner Perkins Caufield & Byers (KPCB) supporting innovative entrepreneurial startup companies in the firm’s life sciences practice. Before joining KPCB, Dana served in a variety of leadership roles at Guidant, including President of Vascular Intervention. He currently serves on the board of directors of Inspire Medical Systems (NYSE: INSP) and previously served on the Board of Directors at telehealth platform company Teladoc, Inc. (TDOC), California Healthcare Institute, Lucile Packard Children’s Hospital at Stanford University, and the Cardiovascular Research Foundation, along with several other private innovative medical device start-ups. Dana received his B.A. from Lafayette College and holds an M.B.A. from the University of Southern California.